LNAI Lunai Bioworks Inc.
AI brief AI-written, not reviewed by a person
Latest filings show Lunai Bioworks Inc. with a negative stockholders’ equity of -9,024,946 USD as of 2026-06-30, and total assets of 9,941,788 USD with total liabilities of 18,966,734 USD at the same date; for the year ended 2026-06-30, net income was -3,562,479 USD and operating loss reached -8,697,933 USD, while revenue for the 12 months to 2026-06-30 was 51,992 USD. Diluted EPS for the 12 months to 2026-06-30 is -1.06 USD per share, compared to -86.27 USD per share for the 12 months to 2025-06-30. The 2026-06-30 cash and equivalents stood at 1,713,653 USD, down from 3,155,272 USD at 2026-03-31, with significant cash balance volatility reflected across the latest two quarterly periods.
- As of 2026-06-30, total assets are 9,941,788 USD and total liabilities are 18,966,734 USD, resulting in stockholders’ equity of -9,024,946 USD. [1][2][3]
- Net income for the 12 months to 2026-06-30 is -3,562,479 USD, with operating income for the same 12 months of -8,697,933 USD and revenue of 51,992 USD. [1][2][3]
- Diluted EPS (year) for 12 months to 2026-06-30 is -1.06 USD per share, compared to -86.27 USD per share for the 12 months to 2025-06-30. [1]
- Cash and equivalents at 2026-06-30 are 1,713,653 USD, down from 3,155,272 USD at 2026-03-31. [1]
Written by OpenVibe.AI from the SEC numbers and filings on this page, not reviewed by a person. Informational only; not investment advice. Written from figures and filings up to (gpt-5-nano-2025-08-07).
Observations
| Metric | Value | Observed | Source | Retrieved | Freshness |
|---|---|---|---|---|---|
| Revenue (quarter) (3 months to 2026-03-31) | 20,942 USD | sec-companyfacts | current | ||
| Revenue (year) (12 months to 2026-06-30) | 51,992 USD | sec-companyfacts | current | ||
| Net income (quarter) (3 months to 2026-03-31) | -2,571,394 USD | sec-companyfacts | current | ||
| Net income (year) (12 months to 2026-06-30) | -3,562,479 USD | sec-companyfacts | current | ||
| Operating income (quarter) (3 months to 2026-03-31) | -1,477,260 USD | sec-companyfacts | current | ||
| Operating income (year) (12 months to 2026-06-30) | -8,697,933 USD | sec-companyfacts | current | ||
| Diluted EPS (quarter) (3 months to 2026-03-31) | -0.1 USD/shares | sec-companyfacts | current | ||
| Diluted EPS (year) (12 months to 2026-06-30) | -1.06 USD/shares | sec-companyfacts | current | ||
| Operating cash flow (quarter) (3 months to 2025-09-30) | -1,349,110 USD | sec-companyfacts | current | ||
| Operating cash flow (year) (12 months to 2026-06-30) | -5,288,197 USD | sec-companyfacts | current | ||
| Total assets (at 2026-06-30) | 9,941,788 USD | sec-companyfacts | current | ||
| Total liabilities (at 2026-06-30) | 18,966,734 USD | sec-companyfacts | current | ||
| Stockholders' equity (at 2026-06-30) | -9,024,946 USD | sec-companyfacts | current | ||
| Cash and equivalents (at 2026-06-30) | 1,713,653 USD | sec-companyfacts | current | ||
| Shares outstanding (at 2026-10-13) | 5,034,452 shares | sec-companyfacts | current |
Context
No reviewed context has been published for LNAI. The observations and documents below are shown as their sources stated them.
Documents
Source freshness
| Source | Freshness | Last successful fetch | Stale after | Sources reports |
|---|---|---|---|---|
| SEC EDGAR: company financial facts (XBRL) sec-companyfacts | current | 10080 min | ok | |
| SEC EDGAR: latest XBRL filings sec-xbrl-filings | current | 45 min | healthy |
Watch this instrument
Sign in to add LNAI to a private watchlist or to get an alert when a new document or observation arrives.
Machine-readable: LNAI.json (the same data with every timestamp and source).
Information only — not investment advice; no trading here. OpenVibe.Trade holds no money or assets, takes no orders and gives no personal recommendations.